L-arabinose exerts probiotic functions by improving gut microbiota and metabolism in vivo and in vitro
Shasha Xiang, Ge Yin, Yalin Zhang, Xuan Bao, Xiaoming Su, Lihua Shi, Yanting Xia, Haoying Han, Jian Ying, Shiyun Lai, Jie Chen, Xuan Zhu
Abstract
Prior investigations have primarily focused on the impact of L-arabinose on gut microbiota, with limited exploration into the dual mechanisms of L-arabinose on microbiota and metabolism both in vivo and in vitro. Thus, this study aimed to elucidate the anti-inflammatory effects of 5 % L-arabinose under different diet in mice. Additionally, a colon simulation system (CDMN) with utilizing 1.72 % (w/v) L-arabinose in the lumen and mucus layers, to provide further insights into the underlying mechanisms. The results revealed that L-arabinose significantly altered the gut microbiome structure, particularly elevating Bifidobacterium and short-chain fatty acids (SCFAs) both in vivo and in vitro. Subsequent in vitro experiments confirmed that L-arabinose increased the relative abundance of SCFAs-producing bacteria, facilitated linoleic acid metabolism, and enhanced downstream metabolites (12,13-DHOME, 9,10-DHOME), potentially mediated by Bifidobacterium in the descending colon. These findings underscore the role of L-arabinose in modulating intestinal flora and metabolism, thereby promoting intestinal and body health.